Dynamic Regulation of Collagens, Proteases, Their Inhibitors, and Cell Death in Experimental Asthma in Mice
Authors:
- Marlena TyneckaMTMarlena Tynecka
- Agnieszka TarasikATAgnieszka Tarasik
- Bartosz HanczarukBHBartosz Hanczaruk
- Adrian JanucikAJAdrian Janucik
- Krystian CzolpinskiKCKrystian Czolpinski
- Alicja WalewskaAWAlicja Walewska
- Arkadiusz ZbikowskiAZArkadiusz Zbikowski
- Anna ZellerAZAnna Zeller
- Agnieszka Kulczynska‐PrzybikAgnieszka Kulczynska‐Przybik
- Magdalena NiemiraMNMagdalena Niemira
- Joanna Reszec‐GielazynJRJoanna Reszec‐Gielazyn
- Barbara MroczkoBMBarbara Mroczko
Open Access
Abstract
Asthma is a complex airway disorder driven by diverse immunological pathways. While type 2 (T2)‐mediated inflammation is well characterized, the mechanisms underlying T2‐low (also referred to as mixed inflammatory phenotype) or non‐T2‐mediated asthma, often associated with Th1/Th17‐driven immune responses and high pulmonary neutrophilic inflammation, remain poorly understood. This study investigates airway remodeling in acute and chronic experimental asthma models induced by house dust mite extract to elucidate inflammatory and structural changes. Two acute T2‐low models demonstrated pronounced airway inflammation characterized by goblet cell hyperplasia, collagen deposition, and significant upregulation of extracellular matrix remodeling and fibroblast activation. In contrast, the chronic Th17‐mediated model exhibited reduced ECM deposition, increased matrix metalloproteinase (MMP) activity, and a distinct molecular signature dominated by IL‐17A‐driven pathways, indicative of ECM degradation and structural instability. Furthermore, the acute models showed immune cell apoptosis as the predominant cell death mechanism. In contrast, the chronic inflammation model was marked by necroptosis localized to structural lung cells, contributing to persistent inflammation and remodeling. Our findings provide new insights into the distinct immunopathological mechanisms underlying airway remodeling and fibrosis in T2‐low and Th17‐mediated asthma phenotypes. The study emphasizes the need for advanced preclinical models and targeted therapeutic strategies to address ECM dysregulation and chronic inflammation to progress in airway remodeling treatment in asthma.Keywords
Funding Information
- Narodowe Centrum Badań i Rozwoju (POLTUR3/MT‐REMOD/2/2019)
- Türkiye Bilimsel ve Teknolojik Araştırma Kurumu (218S757)
- Uniwersytet Medyczny w Bialymstoku
This publication has 66 references indexed in Scilit:
- Airway epithelial ITGB4 deficiency induces airway remodeling in a mouse modelJournal of Allergy and Clinical Immunology, 2022
- Human intestinal myofibroblasts deposited collagen VI enhances adhesiveness for T cells – A novel mechanism for maintenance of intestinal inflammationMatrix Biology, 2022
- Mast cell chymase regulates extracellular matrix remodeling-related events in primary human small airway epithelial cellsJournal of Allergy and Clinical Immunology, 2022
- Airway remodeling: Shifting the trigger point for exacerbations in asthmaJournal of Allergy and Clinical Immunology, 2021
- The basic immunology of asthmaCell, 2021
- Ceramide in apoptosis and oxidative stress in allergic inflammation and asthmaJournal of Allergy and Clinical Immunology, 2020
- Clearance of apoptotic cells by lung alveolar macrophages prevents development of house dust mite-induced asthmatic lung inflammationJournal of Allergy and Clinical Immunology, 2020
- Role of airway epithelial cells in the development of different asthma phenotypesCellular Signalling, 2020
- Macrophage Metabolism of Apoptotic Cell-Derived Arginine Promotes Continual Efferocytosis and Resolution of InjuryCell Metabolism, 2020
- The high and lows of type 2 asthma and mouse modelsJournal of Allergy and Clinical Immunology, 2020